Skip to main content
. Author manuscript; available in PMC: 2012 Aug 16.
Published in final edited form as: J Am Stat Assoc. 2012 Jan 31;107(497):318–330. doi: 10.1080/01621459.2012.656021

Table 3.

Summary of fitting proportional odds models for HIVNET012 data

Parm Est. s.d. CI
NVP 0.265 0.121 (0.027, 0.502)
NVP×Time −8.52×10−5 6.20×10−5 (−2.10×10−4, 4.00×10−5)
CD4+ and VL versus Low risk
 Intermediate risk −0.026 0.018 (−0.061, 0.009)
 High risk −0.052 0.033 (−0.116, 0.012)

NVP, indicator of Nevirapine (versus AZT); Est., parameter estimate; s.d., standard error; CI, 95% confidence interval; Low risk, CD4+>350, VL≤50,000; Intermediate risk, CD4+>350, VL>50,000 or CD4+≤350, VL≤50,000; High risk, CD4+≤350, VL>50,000.